新生児スクリーニングは、出生直後の新生児の遺伝性疾患、代謝障害、先天性疾患を特定するために設計された公衆衛生プログラムです。血液スポット検査、聴力検査、パルスオキシメトリーなどの一連の検査を通じて、医療提供者は、治療しなければすぐには明らかにならないが深刻な健康問題につながる可能性のある状態を検出できます。早期発見により、タイムリーな介入が可能になり、障害や生命を脅かす合併症を予防する可能性が高まります。2023年の世界の新生児スクリーニング市場価値は12億4000万ドルで、2029年には21億6000万ドルに達すると見込まれています。
新生児スクリーニング市場は、主にスクリーニング技術の進歩により、長年にわたって大幅な成長を遂げてきました。タンデム質量分析、DNAアッセイ、パルスオキシメトリーなどのイノベーションにより、新生児で検出できる条件の精度、速度、範囲が大幅に改善されました。これらの進歩によって、早期で信頼性の高い診断が可能になり、タイムリーな介入と健康状態の改善につながる可能性があり、最終的には病院での高度なスクリーニングツールと機器の需要を促進し、政府が必須のスクリーニングプログラムを義務付け、早期診断と治療の重要性についての認識の高まりが市場の成長をさらに推進しています。AIや機械学習に基づく新生児スクリーニング、ポイントオブケア検査、ゲノム・分子技術の進歩、スクリーニングパネルの拡大、新興市場、遠隔医療の拡大など、その他の重要なトレンドが市場の成長をさらに牽引すると予想されます。世界の新生児スクリーニングの市場価値は、2024年から2029年の予測期間中に9.86%のCAGRで成長すると予測されます。
目次
Table of Contents
1. Executive Summary
2. Introduction
2.1 Newborn Screening: An Overview
2.1.1 Definition of Newborn Screening
2.1.2 Continuous Benefits and Importance of Newborn Screening
2.2 Newborn Screening Segmentation: An Overview
2.2.1 Newborn Screening Segmentation
3. Global Market Analysis
3.1 Global Newborn Screening Market: An Analysis
3.1.1 Global Newborn Screening Market: An Overview
3.1.2 Global Newborn Screening Market by Value
3.1.3 Global Newborn Screening Market by Product
3.1.4 Global Newborn Screening Market by Technology
3.1.5 Global Newborn Screening Market by Test Type
3.1.6 Global Newborn Screening Market by End User
3.1.7 Global Newborn Screening Market by Region
3.2 Global Newborn Screening Market: Product Analysis
3.2.1 Global Newborn Screening Market by Product: An Overview
3.2.2 Global Newborn Screening Instruments Market by Value
3.2.3 Global Newborn Screening Instruments Market by Product
3.2.4 Global Newborn Screening Instruments Market Product by Value
3.2.5 Global Newborn Screening Reagents and Assays Market by Value
3.2.6 Global Newborn Screening Reagents & Assays Market by Product
3.2.7 Global Newborn Screening Reagents and Assays Market Product by Value
3.3 Global Newborn Screening Market: Technology Analysis
3.3.1 Global Newborn Screening Market by Technology: An Overview
3.3.2 Global Tandem Mass Spectrometry Newborn Screening Market by Value
3.3.3 Global Pulse Oximetry Newborn Screening Market by Value
3.3.4 Global Immunoassays and Enzymatic Assays Newborn Screening Market by Value
3.3.5 Global DNA Assays Newborn Screening Market by Value
3.3.6 Global Electrophoresis Newborn Screening Market by Value
3.3.7 Global Others Newborn Screening Market by Value
3.4 Global Newborn Screening Market: Test Type Analysis
3.4.1 Global Newborn Screening Market by Test Type: An Overview
3.4.2 Global Dry Blood Spot Newborn Screening Market by Value
3.4.3 Global Critical Congenital Heart Diseases (CCHD) Newborn Screening Market by Value
3.4.4 Global Hearing Newborn Screening Market by Value
3.4.5 Global Others Newborn Screening Market by Value
3.5 Global Newborn Screening Market: End User Analysis
3.5.1 Global Newborn Screening Market by End User: An Overview
3.5.2 Global Hospitals and Clinics Newborn Screening Market by Value
3.5.3 Global Diagnostic Labs Newborn Screening Market by Value
4. Regional Market Analysis
4.1 North America Newborn Screening Market: An Analysis
4.1.1 North America Newborn Screening Market: An Overview
4.1.2 North America Newborn Screening Market by Value
4.1.3 North America Newborn Screening Market by Region
4.1.4 The US Newborn Screening Market by Value
4.1.5 The US Newborn Screening Market Product by Value
4.1.6 The US Newborn Screening Instruments Market by Product
4.1.7 The US Newborn Screening Reagents and Assays Market by Product
4.1.8 The US Newborn Screening Market Test Type by Value
4.1.9 Canada Newborn Screening Market by Value
4.1.10 Mexico Newborn Screening Market by Value
4.2 Europe Newborn Screening Market: An Analysis
4.2.1 Europe Newborn Screening Market: An Overview
4.2.2 Europe Newborn Screening Market by Value
4.2.3 Europe Newborn Screening Market by Region
4.2.4 Germany Newborn Screening Market by Value
4.2.5 United Kingdom Newborn Screening Market by Value
4.2.6 France Newborn Screening Market by Value
4.2.7 Italy Newborn Screening Market by Value
4.2.8 Spain Newborn Screening Market by Value
4.2.9 Rest of Europe Newborn Screening Market by Value
4.3 Asia Pacific Newborn Screening Market: An Analysis
4.3.1 Asia Pacific Newborn Screening Market: An Overview
4.3.2 Asia Pacific Newborn Screening Market by Value
4.3.3 Asia Pacific Newborn Screening Market by Region
4.3.4 China Newborn Screening Market by Value
4.3.5 Japan Newborn Screening Market by Value
4.3.6 India Newborn Screening Market by Value
4.3.7 South Korea Newborn Screening Market by Value
4.3.8 Rest of Asia Pacific Newborn Screening Market by Value
4.4 Rest of the World Newborn Screening Market: An Analysis
4.4.1 Rest of the World Newborn Screening Market: An Overview
4.4.2 Rest of the World Newborn Screening Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19 on Global Newborn Screening Market
5.2 Post COVID-19 Impact on Global Newborn Screening Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rising Birth Rates and Population Growth
6.1.2 Upsurge in Healthcare Expenditure
6.1.3 Rising Burden of Congenital Diseases
6.1.4 Government Initiatives and Mandatory Screening Programs
6.1.5 Increased Awareness and Education
6.2 Challenges
6.2.1 Lack of Standardization
6.2.2 Regulatory Hurdles
6.3 Market Trends
6.3.1 Artificial Intelligence and Machine Learning Based Newborn Screening
6.3.2 Point-of-Care Testing (POCT)
6.3.3 Advances in Genomic and Molecular Technologies
6.3.4 Expansion of Screening Panels
6.3.5 Growth in Emerging Markets
6.3.6 Telehealth Expansion
7. Competitive Landscape
7.1 Global Newborn Screening Market: Recent Developments
7.2 Global Newborn Screening Market Players: Product Comparison
8. Company Profiles
8.1 Agilent Technologies, Inc.
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Revvity, Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy
8.3 Waters Corporation
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy
8.5 Masimo Corporation
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Medtronic plc
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy
8.7 LifeCell International Pvt. Ltd.
8.7.1 Business Overview
8.7.2 Business Strategy
8.8 Zentech
8.8.1 Business Overview
8.8.2 Business Strategy
8.9 Trivitron Healthcare
8.9.1 Business Overview
8.9.2 Business Strategy
8.10 MRC Holland
8.10.1 Business Overview
8.10.2 Business Strategy
8.11 Natus Medical Incorporated
8.11.1 Business Overview
8.12 Baebies, Inc.
8.12.1 Business Overview
List of Figures
Figure 1: Continuous Benefits and Importance of Newborn Screening
Figure 2: Newborn Screening Segmentation
Figure 3: Global Newborn Screening Market by Value; 2019-2023 (US$ Billion)
Figure 4: Global Newborn Screening Market by Value; 2024-2029 (US$ Billion)
Figure 5: Global Newborn Screening Market by Product; 2023 (Percentage, %)
Figure 6: Global Newborn Screening Market by Technology; 2023 (Percentage, %)
Figure 7: Global Newborn Screening Market by Test Type; 2023 (Percentage, %)
Figure 8: Global Newborn Screening Market by End User; 2023 (Percentage, %)
Figure 9: Global Newborn Screening Market by Region; 2023 (Percentage, %)
Figure 10: Global Newborn Screening Instruments Market by Value; 2019: 2023 (US$ Million)
Figure 11: Global Newborn Screening Instruments Market by Value; 2024-2029 (US$ Billion)
Figure 12: Global Newborn Screening Instruments Market by Product; 2023 (Percentage, %)
Figure 13: Global Newborn Screening Instruments Market Product by Value; 2019-2023 (US$ Million)
Figure 14: Global Newborn Screening Instruments Market Product by Value; 2024-2029 (US$ Million)
Figure 15: Global Newborn Screening Reagents and Assays Market by Value; 2019-2023 (US$ Million)
Figure 16: Global Newborn Screening Reagents and Assays Market by Value; 2024-2029 (US$ Million)
Figure 17: Global Newborn Screening Reagents & Assays Market by Product; 2023 (Percentage, %)
Figure 18: Global Newborn Screening Reagents and Assays Market Product by Value; 2019-2023 (US$ Million)
Figure 19: Global Newborn Screening Reagents and Assays Market Product by Value; 2024-2029 (US$ Million)
Figure 20: Global Tandem Mass Spectrometry Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 21: Global Tandem Mass Spectrometry Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 22: Global Pulse Oximetry Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 23: Global Pulse Oximetry Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 24: Global Immunoassays and Enzymatic Assays Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 25: Global Immunoassays and Enzymatic Assays Newborn Screening Market by Value; 2024: 2029 (US$ Million)
Figure 26: Global DNA Assays Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 27: Global DNA Assays Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 28: Global Electrophoresis Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 29: Global Electrophoresis Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 30: Global Others Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 31: Global Others Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 32: Global Dry Blood Spot Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 33: Global Dry Blood Spot Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 34: Global Critical Congenital Heart Diseases (CCHD) Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 35: Global Critical Congenital Heart Diseases (CCHD) Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 36: Global Hearing Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 37: Global Hearing Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 38: Global Others Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 39: Global Others Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 40: Global Hospitals and Clinics Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 41: Global Hospitals and Clinics Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 42: Global Diagnostic Labs Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 43: Global Diagnostic Labs Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 44: North America Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 45: North America Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 46: North America Newborn Screening Market by Region; 2023 (Percentage, %)
Figure 47: The US Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 48: The US Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 49: The US Newborn Screening Market Product by Value; 2023-2029 (US$ Million)
Figure 50: The US Newborn Screening Instruments Market by Product; 2023 (Percentage, %)
Figure 51: The US Newborn Screening Reagents and Assays Market by Product; 2023 (Percentage, %)
Figure 52: The US Newborn Screening Market Test Type by Value; 2023-2029 (US$ Million)
Figure 53: Canada Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 54: Canada Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 55: Mexico Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 56: Mexico Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 57: Europe Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 58: Europe Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 59: Europe Newborn Screening Market by Region; 2023 (Percentage, %)
Figure 60: Germany Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 61: Germany Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 62: United Kingdom Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 63: United Kingdom Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 64: France Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 65: France Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 66: Italy Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 67: Italy Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 68: Spain Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 69: Spain Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 70: Rest of Europe Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 71: Rest of Europe Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 72: Asia Pacific Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 73: Asia Pacific Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 74: Asia Pacific Newborn Screening Market by Region; 2023 (Percentage, %)
Figure 75: China Newborn Screening Market by Value, 2019-2023 (US$ Million)
Figure 76: China Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 77: Japan Newborn Screening Market by Value, 2019-2023 (US$ Million)
Figure 78: Japan Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 79: India Newborn Screening Market by Value, 2019-2023 (US$ Million)
Figure 80: India Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 81: South Korea Newborn Screening Market by Value, 2019-2023 (US$ Million)
Figure 82: South Korea Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 83: Rest of Asia Pacific Newborn Screening Market by Value, 2019-2023 (US$ Million)
Figure 84: Rest of Asia Pacific Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 85: Rest of the World Newborn Screening Market by Value; 2019-2023 (US$ Million)
Figure 86: Rest of the World Newborn Screening Market by Value; 2024-2029 (US$ Million)
Figure 87: Global Population; 2020-2024 (Billion)
Figure 88: The US National Health Expenditure Per Capita; 2020-2031 (US$ Thousand)
Figure 89: Global Artificial Intelligence (AI) in Healthcare Market; 2021-2030 (US$ Billion)
Figure 90: Agilent Technologies, Inc. Revenue by Segments; 2022 (Percentage, %)
Figure 91: Revvity, Inc. Revenue by Segments; 2023 (Percentage, %)
Figure 92: Waters Corp. Net Sales by Product; 2023 (Percentage, %)
Figure 93: Waters Corp. Net Sales by Service; 2023 (Percentage, %)
Figure 94: Bio: Rad Laboratories, Inc. Net Sales by Segments; 2023 (Percentage, %)
Figure 95: Masimo Corporation Revenue by Segments; 2023 (Percentage, %)
Figure 96: Medtronic plc Net Sales by Segment: 2023 (Percentage, %)
Table 1: Global Newborn Screening Market Players: Product Comparison; 2024
